Cobimetinib recalls

The FDA has published 1 recall involving Cobimetinib since 2017. The latest was reported on 12 Apr 2017. Most were for potency & assay. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls1since 2017

Last 12 months0reported

Class I00% of total

Ongoing0latest 12 Apr 2017

Recalls per month, last 24 months

click a bar for that month

0Dec '24 0 0 0Mar 0 0 0Jun 0 0 0Sep 0 0 0Dec 0 0 0Mar 0 0 0Jun 0 0 0Sep 0 0

Severity split

Class I 0 0%Class II 1 100%Class III 0 0%

Why cobimetinib is recalled

Potency & Assay1100%

Companies

Genentech1100%

By year

20171100%

All cobimetinib recalls, newest first

1 total

Reported	Class	Recall	Company	Reason	Where
12 Apr 2017Drug	CLASS II	Cotellic (cobimetinib) Tablets, 20 mg recalled by GenentechCotellic	Genentech	Potency & Assay	IL, NJ

Should you stop taking Cobimetinib?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.